Microport Scientific (MCRPF) 0.6800 $MCRPF
Neurovascular Interventions - EU Analysis and Market Forecasts to 2020
M2 - Wed May 07, 8:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nd4wcl/medipoint) has announced the addition of the "MediPoint: Neurovascular Interventions - EU Analysis and Market Forecasts" report to their offering. The global neurovascular interventions market is a vast, double-digit market that consists of innovative and emerging technologies. Rapid advances in the field of neurovascular interventions and development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. The neurovascular interventions market consists of four device segments including embolization, revascularization, mechanicalthrombectomy and access/support devices. The neurovascular interventions market in the 5EU is a vast and dynamic market that consists of innovative and emerging technologies. Neurointerventional devices can be used to treat a variety of cerebrovascular indications such as intracranial aneurysms, AVMs, and dural AVFs, atherosclerotic disease, and stroke. In this report, the neurointerventional market encompasses embolization, revascularization, mechanical thrombectomy, and access/support devices. Scope - An overview of Neurovascular, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized the EU Neurovascular market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for Neurovascular. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the Neurovascular sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors Companies Mentioned - BALT Extrusion - Covidien - Johnson & Johnson - Penumbra - Stryker Corporation - Terumo Corporation - Abbott Vascular - Boston Scientific Corporation - Cook Medical - Gore Medical - Medtronic - Aachen Resonance - Acandis - B. Braun - Blockade Medical - Contego Medical - Gardia Medical - InspireMD - ITGI Medical - Medikit - Merlin MD - MicroPort Scientific Corporation - Minvasys - Neuravi - Optimed - Phenox GmBH - Reverse Medical - Sequent Medical - Valor Medical For more information visit http://www.researchandmarkets.com/research/nd4wcl/medipoint
MediPoint Report: Neurovascular Interventions - APAC Analysis and Market Forecasts to 2020
M2 - Wed May 07, 8:38AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cn25dz/medipoint) has announced the addition of the "MediPoint: Neurovascular Interventions - APAC Analysis and Market Forecasts" report to their offering. The APAC neurovascular interventions market is a vast and dynamic market that consists of innovative and emerging technologies. Neurointerventional devices can be used to treat a variety of cerebrovascular indications such as intracranial aneurysms, AVMs, and dural AVFs, atherosclerotic disease, and stroke. In this report, the neurointerventional market encompasses embolization, revascularization, mechanical thrombectomy, and access/support devices. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Clinical Outcomes 4 Industry Overview 5 Unmet Needs 6 Market Opportunity Analysis 7 Market Drivers and Barriers 8 Competitive Assessment 9 Pipeline Assessment 10 Clinical Trial Analysis 11 Current and Future Players 12 Market Outlooks 13 Appendix Companies Mentioned - BALT Extrusion - Covidien - Johnson & Johnson - Penumbra - Stryker Corporation - Terumo Corporation - Abbott Vascular - Boston Scientific Corporation - Cook Medical - Gore Medical - Medtronic - Aachen Resonance - Acandis - B. Braun - Blockade Medical - Contego Medical - Gardia Medical - InspireMD - ITGI Medical - Medikit - Merlin MD - MicroPort Scientific Corporation - Minvasys - Neuravi - Optimed - Phenox GmBH - Reverse Medical - Sequent Medical - Valor Medical For more information visit http://www.researchandmarkets.com/research/cn25dz/medipoint
MediPoint: Neurovascular Interventions - South America Analysis and Market Forecasts to 2020
M2 - Wed May 07, 8:27AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zzfs96/medipoint) has announced the addition of the "MediPoint: Neurovascular Interventions - South America Analysis and Market Forecasts" report to their offering. The neurovascular interventions market will be driven by the rising prevalence of disease, the growing aging population, and the potential cost savings. The adoption of innovative technologies such as flow diverters and stent retrievers in Brazil will depend on the cost of, and availability of reimbursement for these devices. Flow diverters and stent retrievers are currently not reimbursed by the Brazilian public healthcare system and are associated with high costs. Scope - An overview of Neurovascular Interventions, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized South America Neurovascular Interventions market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for Neurovascular Interventions. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the Neurovascular Interventions sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors Companies Mentioned - BALT Extrusion - Covidien - Johnson & Johnson - Penumbra - Stryker Corporation - Terumo Corporation - Abbott Vascular - Boston Scientific Corporation - Cook Medical - Gore Medical - Medtronic - Aachen Resonance - Acandis - B. Braun - Blockade Medical - Contego Medical - Gardia Medical - InspireMD - ITGI Medical - Medikit - Merlin MD - MicroPort Scientific Corporation - Minvasys - Neuravi - Optimed - Phenox GmBH - Reverse Medical - Sequent Medical - Valor Medical For more information visit http://www.researchandmarkets.com/research/zzfs96/medipoint
MediPoint: US Neurovascular Interventions Analysis and Market Forecasts 2014-2020
M2 - Wed May 07, 8:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/b4sqvw/medipoint) has announced the addition of the "MediPoint: Neurovascular Interventions - US Analysis and Market Forecasts" report to their offering. The neurovascular interventions market in the US to reach $702m by 2020, increasing slowly throughout the forecast period. The neurovascular interventions market will be driven by: the rising prevalence of cerebrovascular disease; the cost savings incurred by government agencies, such as Medicare, and private health insurance companies; and the adoption of innovative technologies such as flow diverters and stent retrievers. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Clinical Outcomes 4 Industry Overview 5 Unmet Needs 6 Market Opportunity Analysis 7 Market Drivers and Barriers 8 Competitive Assessment 9 Pipeline Assessment 10 Clinical Trial Analysis 11 Current and Future Players 12 US Market Outlook 13 Appendix Companies Mentioned - BALT Extrusion - Covidien - Johnson & Johnson - Penumbra - Stryker Corporation - Terumo Corporation - Abbott Vascular - Boston Scientific Corporation - Cook Medical - Gore Medical - Medtronic - Aachen Resonance - Acandis - B. Braun - Blockade Medical - Contego Medical - Gardia Medical - InspireMD - ITGI Medical - Medikit - Merlin MD - MicroPort Scientific Corporation - Minvasys - Neuravi - Optimed - Phenox GmBH - Reverse Medical - Sequent Medical - Valor Medical For more information visit http://www.researchandmarkets.com/research/b4sqvw/medipoint
Wright Medical Group, Inc. Reports 2014 First Quarter Financial Results
Business Wire - Wed Apr 30, 3:01PM CDT
--First Quarter Sales from Continuing Operations Increase 26% As Reported and 26% Constant Currency
Global Electrophysiology Report 2014 - The Current and Future Players
M2 - Wed Apr 30, 9:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8qjsng/medipoint) has announced the addition of the "MediPoint: Electrophysiology - Current and Future Players" report to their offering. The report offers a comprehensive analysis of the global EP market, including development and sales of ablation catheters, diagnostic catheters and lab systems in the US, Germany, Italy, Spain, UK, France, China, India, Japan and Brazil. Included within is an examination of the drivers, opportunities and barriers impacting growth of the EP market worldwide, with an in-depth breakdown of the EP market seven-year global forecast. The report identifies and evaluates key trends and unmet needs shaping the global EP market through 2020, highlighting testimonials from top physicians around the world who are utilizing these devices. Future sales expectations are discussed through careful analysis of EP use adoption patterns in the ten major markets. The report identifies and analyzes the key companies shaping and driving the Electrophysiology market. The report provides insight into the competitive Electrophysiology landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading cardiologists, with in-house analysis conducted by Our team of industry experts. Scope - Investigation of current and future market competition for Electrophysiology - Competitor assessment including device approval analysis. - Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. - Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists using Electrophysiology in clinical practice. Key Topics Covered: 1 List of Tables 2 Introduction 3 Current and Future Players - Biosense Webster - Biotronik - Boston Scientific - CardioFocus - CardioInsight - Hansen Medical - Imricor - Japan Lifeline - Magnetecs Corporation - Medtronic - MicroPort Scientific Company - St. Jude Medical - Stereotaxis - Stryker Sustainability Solutions - Topera Medical 4 Pipeline Product Assessment 4.1 Pipeline Assessment by Development Stage 4.2 Segment Analysis of Pipeline Products - Ablation Catheter Pipeline Products - Diagnostic Catheter Pipeline Products 4.3 Lab Systems - Integrated X-Ray and Robotic Catheter System (Hansen Medical, Philips Healthcare) - ClearTrace System (MRI Interventions) - Robotic Catheter Guidance Lab System (North Carolina State University) - Catheter Guidance Lab System (SCR) 5 Strategic Deals Analysis 5.1 Key Acquisitions - Boston Scientific Acquires C.R. Bard's Electrophysiology Business for $275m - St. Jude Medical Acquires Endosense for $161m - Boston Scientific Acquires Rhythmia Medical for $265m 5.2 Key Partnerships - Philips and Biosense Webster Technology Integration Agreement - Biosense Webster Technology Integration Agreement with GE Healthcare Systems and Siemens Healthcare - Abbott and St. Jude Medical Broaden Alliance in US Cardiovascular Device Market 6 Appendix For more information visit http://www.researchandmarkets.com/research/8qjsng/medipoint
Global Drug-eluting Stent Market 2014-2018 with Abbott Laboratories, Boston Scientific, Medtronic & Terumo Dominating
M2 - Thu Apr 17, 5:16AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c6b9zf/global) has announced the addition of the "Global Drug-eluting Stent Market 2014-2018 with Abbott Laboratories, Boston Scientific, Medtronic & Terumo Dominating" report to their offering. One of the key drivers is the increase in the number of patients suffering from CVD. An unhealthy diet and lack of physical activity are the major factors leading to the increase in the number of people prone to CVD. Increasing demand for minimally-invasive procedures has been witnessed among members of the rapidly aging population across the world, and this is expected to boost the growth of the Global DES market. In addition, the cost efficiencies offered by less invasive methods are likely to increase the demand for the procedures in the near future. Minimally-invasive endovascular procedures are surgeries performed through minute incisions in the body. Such procedures can be used to treat plaque blockages in the arteries of the heart and other vessel walls of peripheral organs such as the kidneys and the brain. The principal advantages of these procedures over conventional surgeries are the short recovery time, the short length of the scars resulting in less physical trauma, low risk of infection, and minimized bleeding, and the shorter hospital stays associated with these surgeries. Further, the report states that the biggest challenge the market is facing is the decline in the ASP of DESs. There has been a steady decline in the prices of DESs worldwide because of the increased competition and the high rate of adoption. The reduction in the ASP has a negative impact on the overall market revenue. Key vendors dominating this space are: - Abbott Laboratories - Boston Scientific Corp - Medtronic Inc. - Terumo Corp. Other vendors mentioned in the report are: - B. Braun Melsungen AG - Biosensors International Ltd - BIOTRONIK SE & Co. KG - Cook Medical Inc. - Lepu Medical Technology Co. Ltd - MicroPort Scientific Corp. - Sorin Group USA Inc. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Types of Drugs - Geographical Segmentation - Key Leading Countries - Rate of Incidence and Prevalence - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/c6b9zf/global
ReFlow Medical and MicroPort Scientific Announce Chinese Alliance
Business Wire - Tue Apr 08, 8:02AM CDT
ReFlow Medical, Inc. (ReFlow) today announced that it has signed an exclusive distribution and sales agreement for ReFlow's suite of peripheral chronic total occlusion (CTO) products with MicroPort Endovascular (MicroPort Endo), a division of MicroPort Scientific Corporation (MicroPort), a leading medical device company in China.
Neurovascular Interventions - Global Analysis and Market Forecasts 2014
M2 - Tue Apr 08, 5:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/95ztzv/medipoint) has announced the addition of the "MediPoint: Neurovascular Interventions - Global Analysis and Market Forecasts" report to their offering. Sales of Neurointerventional Devices by Region In this report, the neurovascular interventions market encompasses embolization, revascularization, mechanical thrombectomy, and access/support devices. In 2013 in the 10MM, the neurovascular interventions market was approximately $1.37bn. We estimate the 2014 sales of neurointerventional devices for cerebrovascular applications to be $1.40bn across the 10 countries covered in this report, which are the US, France, Germany, Italy, Spain, the UK, Japan, China, India, and Brazil. Embolization, revascularization, and mechanical thrombectomy devices can be used for a wide range of cerebrovascular indications including intracranial aneurysms and arteriovenous malformations (AVMs), dural arteriovenous fistulas (DAVFs), atherosclerotic disease, and stroke. Endovascular therapy for neurovascular applications is rapidly expanding and provides effective results. The key drivers for this market during the forecast period are: - The rising prevalence of cerebrovascular disease and its associated risk factors in the major markets covered in this report. - The need for effective therapies that reduce the risk of hemorrhagic and stroke complications, and ensure long-term, reliable outcomes. - The improved outcomes with endovascular coiling for intracranial aneurysm treatment compared with surgical therapy. - The increased use of remodeling techniques such as stent-assisted and balloon-assisted coiling, and the adoption of flow diverters for the treatment of challenging/complex aneurysms (wide-neck, large, and giant aneurysms). - Improved recanalization rates with mechanical thrombectomy systems, where the need for chemical thrombolysis is eliminated, thereby reducing the risk of intracranial hemorrhage. - The cost savings for healthcare payers resulting from the reduced need for repeat procedures. - The increase in patients' disposable income and government insurance coverage in the emerging markets, such as China and India. - The approval and launch of the next-generation of innovative embolization, revascularization, and mechanical thrombectomy devices in the US and Japan. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Clinical Outcomes 4 Industry Overview 5 Unmet Needs 6 Market Opportunity Analysis 7 Market Drivers and Barriers 8 Competitive Assessment 9 Pipeline Assessment 10 Clinical Trial Analysis 11 Current and Future Players 12 Market Outlooks 13 Appendix Companies Mentioned - BALT Extrusion - Covidien - Johnson & Johnson - Penumbra - Stryker Corporation - Terumo Corporation - Abbott Vascular - Boston Scientific Corporation - Cook Medical - Gore Medical - Medtronic - Aachen Resonance - Acandis - B. Braun - Blockade Medical - Contego Medical - Gardia Medical - InspireMD - ITGI Medical - Medikit - Merlin MD - MicroPort Scientific Corporation - Minvasys - Neuravi - Optimed - Phenox GmBH - Reverse Medical - Sequent Medical - Valor Medical For more information visit http://www.researchandmarkets.com/research/95ztzv/medipoint
MediPoint: Electrophysiology - South America Analysis and Market Forecasts to 2020
M2 - Mon Apr 07, 8:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rt6lxw/medipoint) has announced the addition of the "MediPoint: Electrophysiology - South America Analysis and Market Forecasts" report to their offering. Still in its infancy, the electrophysiology (EP) device market has seen significant adoption; as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device price-points fall, and efficacy improves. This continued growth is also driven by technological advancements including the emergence of next-generation ablation technologies, improvements in catheter diagnostics, and advancements in lab systems. Further, as imaging modalities improve, patients are exposed to less radiation than ever before, which will only further drive diagnostics. Training for EP device use is severely limited in Brazil, and although it has been improving over time, it is still not ideal. While manufacturers are willing to sell devices in Brazil, support for device use has been inadequate compared with the US or countries in Europe. As a result, many physicians learn as they go, developing the skills necessary to perform complex ablation from their experiences gained using the devices during simpler procedures. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Segment Analysis 5 Market Outlooks by Geography 6 Strategic Competitive Assessment 7 Current and Future Players 8 Pipeline Product Assessment 9 Strategic Deals Analysis 10 Appendix Companies Mentioned - Biosense Webster - Biotronik - Boston Scientific - CardioFocus - CardioInsight - Hansen Medical - Imricor - Japan Lifeline - Magnetecs Corporation - Medtronic - MicroPort Scientific Company - St. Jude Medical - Stereotaxis - Stryker Sustainability Solutions - Topera Medical For more information visit http://www.researchandmarkets.com/research/rt6lxw/medipoint
MediPoint: Electrophysiology - EU Analysis and Market Forecasts 2020
M2 - Mon Mar 24, 11:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/slft2n/medipoint) has announced the addition of the "MediPoint: Electrophysiology - EU Analysis and Market Forecasts" report to their offering. Still in its infancy, the electrophysiology (EP) device market has seen significant adoption; as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device price-points fall, and efficacy improves. This continued growth is also driven by technological advancements including the emergence of next-generation ablation technologies, improvements in catheter diagnostics, and advancements in lab systems. Further, as imaging modalities improve, patients are exposed to less radiation than ever before, which will only further drive diagnostics. The EP market is dominated by several key players, with the biggest markets being in the US and European Union (EU). With improvements in reimbursement worldwide, as well as advancements of global distribution channels, devices are being sold in more hospitals and ever, and this is only expected to increase. With only a few key players currently in the market, competition remains high as industry leaders fight for valuable market share. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Segment Analysis 5 Market Outlooks by Geography 6 Strategic Competitive Assessment 7 Current and Future Players 8 Pipeline Product Assessment 9 Strategic Deals Analysis 10 Appendix Companies Mentioned - Biosense Webster - Biotronik - Boston Scientific - CardioFocus - CardioInsight - Hansen Medical - Imricor - Japan Lifeline - Magnetecs Corporation - Medtronic - MicroPort Scientific Company - St. Jude Medical - Stereotaxis - Stryker Sustainability Solutions - Topera Medical For more information visit http://www.researchandmarkets.com/research/slft2n/medipoint
MediPoint: Electrophysiology - APAC Analysis and Market Forecasts to 2020
M2 - Thu Mar 20, 10:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/z8kgmv/medipoint) has announced the addition of the "MediPoint: Electrophysiology - APAC Analysis and Market Forecasts" report to their offering. Still in its infancy, the electrophysiology (EP) device market has seen significant adoption; as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device price-points fall, and efficacy improves. This continued growth is also driven by technological advancements including the emergence of next-generation ablation technologies, improvements in catheter diagnostics, and advancements in lab systems. Further, as imaging modalities improve, patients are exposed to less radiation than ever before, which will only further drive diagnostics. Growth in emerging markets is expected to drive sales as developing countries look to implement new EP programs, and hospitals adopt ablation techniques. Lastly, published studies, clinical evidence, and patient awareness will all contribute positively to EP market growth and will provide further evidence of the effectiveness of cardiac catheter ablation. Scope - An overview of electrophysiology, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized APAC electrophysiology market revenue from 2005 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for electrophysiology - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the electrophysiology sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Segment Analysis 5 Market Outlooks by Geography 6 Strategic Competitive Assessment 7 Current and Future Players 8 Pipeline Product Assessment 9 Strategic Deals Analysis 10 Appendix Companies Mentioned - Biosense Webster - Biotronik - Boston Scientific - CardioFocus - CardioInsight - Hansen Medical - Imricor - Japan Lifeline - Magnetecs Corporation - Medtronic - MicroPort Scientific Company - St. Jude Medical - Stereotaxis - Stryker Sustainability Solutions - Topera Medical For more information visit http://www.researchandmarkets.com/research/z8kgmv/medipoint
Concise Analysis of the International Intracranial Stents Market
M2 - Thu Mar 13, 6:28AM CDT
Research and Markets (http://www.researchandmarkets.com/research/r4fntp/intracranial) has announced the addition of the "Concise Analysis of the International Intracranial Stents Market" report to their offering. This report analyzes the worldwide markets for Intracranial Stents in US$ Thousands. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a five-year historic analysis is provided for these markets. The report profiles 16 companies including many key and niche players such as: - Admedes Schuessler GmbH - BALT Extrusion - Cardiatis SA - Codman & Shurtleff, Inc. - Covidien PLC - ITGI Medical Ltd. - Medtronic, Inc. - MicroPort Scientific Corporation - OBEX Medical - Penumbra, Inc. - Stryker Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Market Drivers, Issues & Challenges 3. Product Overview 4. Neurovascular Diseases - An Overview 5. Product Introductions & Approvals 6. Recent Industry Activity 7. Focus On Select Players 8. Global Market Perspective III. Market 1. The United States 2. Europe 3. Rest Of World IV. Competitive Landscape Total Companies Profiled: 16 (including Divisions/Subsidiaries - 18) - The United States (7) - Europe (6) - France (1) - Germany (3) - Rest of Europe (2) - Asia-Pacific (Excluding Japan) (4) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/r4...tracranial About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Electrophysiology Market Value to Almost Double by 2020, as Arrhythmia Incidence Continues to Grow
M2 - Tue Mar 04, 3:40AM CST
Research and Markets (http://www.researchandmarkets.com/research/szcgxs/medipoint) has announced the addition of the "MediPoint: Electrophysiology - Global Analysis and Market Forecasts" report to their offering. Global Electrophysiology Market Value to Almost Double by 2020, as Arrhythmia Incidence Continues to Grow The global electrophysiology (EP) market, consisting of ablation catheters, diagnostic catheters and lab systems, is set to experience rapid growth in value over the coming years, climbing from approximately $1.56 billion in 2013 to $2.93 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 9.5%, says research and consulting firm The authors. The company's new report* forecasts that standard diagnostic catheters will achieve the largest revenue in the EP market by 2020, with a share of $2,493 million, followed by advanced diagnostic catheters and standard ablation catheters, with shares of $1,223 million and $575 million, respectively. According to the authors, this rapid EP industry growth is due to an increasing incidence of arrhythmia, along with rising market penetration of diagnostic and ablation catheters in the Asia-Pacific and South American regions. Rob Littlefield, MSc, Senior Analyst covering Medical Devices, says: Medical centers that support ablation are increasingly desirable as the global occurrence of cardiac dyssynchrony continues to rise. While atrial fibrillation and ventricular fibrillation are the most common indications for treatment, heart failure, diabetes and obesity can all contribute to ongoing rhythm management concerns. The authors states that the current EP market is extremely competitive and dominated by several key players, which must continue to innovate in the face of mounting price pressure and strict regulation, as new entrants battle to gain market share. Up-and-coming technologies in development, including alternative forms of energy such as cryo-, ultrasound- and laser-ablation, as well as advanced mapping and navigation technologies, promise to increase product sales and new account openings. Meanwhile, industry standards continue to develop in relation to ablation strategies for treatment, therefore improving patient outcomes, Littlefield concludes. This report provides a comprehensive analysis of the global electrophysiology market, including development and sales of ablation catheters, diagnostic catheters and lab systems in the US, Germany, Italy, Spain, the UK, France, China, India, Japan and Brazil. Key Topics Covered: List of Tables List of Figures Introduction Industry Overview Segment Analysis Market Outlooks by Market Segment Market Outlooks by Geography Strategic Competitive Assessment Current and Future Players Pipeline Product Assessment Strategic Deals Analysis Appendix List of Tables List of Figures Companies Mentioned Biosense Webster Biotronik Boston Scientific CardioFocus CardioInsight Hansen Medical Imricor Japan Lifeline Magnetecs Corporation Medtronic MicroPort Scientific Company St. Jude Medical Stereotaxis Stryker Sustainability Solutions Topera Medical For more information visit http://www.researchandmarkets.com/research/szcgxs/medipoint About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Drug-eluting Stent Market 2014-2018: The Biggest Challenge the Market is Facing is the Decline in the ASP of DESs
M2 - Mon Feb 17, 8:46AM CST
Research and Markets (http://www.researchandmarkets.com/research/gprmns/global) has announced the addition of the "Global Drug-eluting Stent Market 2014-2018" report to their offering. The analysts forecast the Global Drug-eluting Stent (DES) market to grow at a CAGR of 5.79 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing prevalence of CVD. The Global Drug-eluting Stent (DES) market has also been witnessing the increasing demand for minimally invasive procedures. However, the decline in the average selling price of drug eluting stents could pose a challenge to the growth of this market. Key vendors dominating this space are Abbott Laboratories, Boston Scientific Corp., Medtronic Inc., and Terumo Corp. Other vendors mentioned in the report are B. Braun Melsungen AG, Biosensors International Ltd., BIOTRONIK SE & Co. KG, Cook Medical Inc., Lepu Medical Technology Co. Ltd., MicroPort Scientific Corp., and Sorin Group USA Inc. Commenting on the report, an analyst from the team said: Increasing demand for minimally-invasive procedures has been witnessed among members of the rapidly aging population across the world, and this is expected to boost the growth of the Global DES market. In addition, the cost efficiencies offered by less invasive methods are likely to increase the demand for the procedures in the near future. Minimally-invasive endovascular procedures are surgeries performed through minute incisions in the body. Such procedures can be used to treat plaque blockages in the arteries of the heart and other vessel walls of peripheral organs such as the kidneys and the brain. The principal advantages of these procedures over conventional surgeries are the short recovery time, the short length of the scars resulting in less physical trauma, low risk of infection, and minimized bleeding, and the shorter hospital stays associated with these surgeries. According to the report, one of the key drivers is the increase in the number of patients suffering from CVD. An unhealthy diet and lack of physical activity are the major factors leading to the increase in the number of people prone to CVD. For more information visit http://www.researchandmarkets.com/research/gprmns/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
3 Catalysts To Catapult Global Coronary Stent Market To $13 Billion by 2019
M2 - Mon Jan 27, 9:45AM CST
Research and Markets (http://www.researchandmarkets.com/research/3rr9nj/3_catalysts_to) has announced the addition of the "3 Catalysts To Catapult Global Coronary Stent Market To $13 Billion" report to their offering. The global coronary stent market is expected to be over $13 billion by 2019, despite the current downward trend in the US, the largest market, and declining selling prices globally. Increasing PCI (percutaneous coronary intervention) procedures triggered by the rising prevalence of CAD (coronary artery disease), novel technologies in pipeline addressing the unmet needs, uptake of Bioabsorbable stents and impressive growth in APAC region have the potential to upswing the fortunes of the market that has remained stagnant for a few years. The market study takes into account various global clinical studies and pipeline products and it suggests that the coronary stent pipeline is clustered with new generation Drug Eluting Stent (DES), bioactive stents, bioabsorbable technology and stents for the niche segments such as complex and bifurcated vessels. Altering the trend, small to medium size companies from the developing economies are ambitiously conducting clinical studies to win the approvals and expand the use of devices for new indications. The stent market globally and in the developed nations is largely controlled by three players - Abbott Laboratories, Boston Scientific, and Medtronic. While in developing economies, small and medium players from Asia and Europe have a considerable share in terms of volume. This comprehensive, 465 page global strategic business report is authored by a team of sector analysts who used rigorous primary and secondary research and robust analytical models to provide strategic insight and to forecast for all major stent types BMS, DES, Bioabsorbable stents in leading 23 geographies. Data at global, continents, economic zones, and country level: - Market size of coronary stents in terms - value and volume (2005-2019) for BMS, DES and Bioabsorbables (Bioresorbable - BVS) - Market growth rates (2005-2019) - Average prices of various stents in all the covered geographies (2005-2019) - Number of PCI procedures - Analytical comparison between different continents and economic regions - Market dynamics - market trends, drivers, restrains, issues, competitive landscape - Detailed pipeline and clinical studies - Product approval status - major geographies - Industry consolidation, partnerships, product launches, approvals and recalls - Detailed company profiles of around 70 companies from different levels of value chain Key Topics Covered: 1. Charts & Tables 2. Executive Summary 3. Market at a Glance 4. Introduction to Stents 5. Coronary Stents 6. Types of Stents 7. Approvals 8. Competitive Landscape 9. Clinical Studies 10.Coronary Stents - Market Drivers and Restrains 11.Overview: Market trends 12.Approvals Driving the Growth 13. Market Data 14.Company Profiles 15.Recent Events 16.Appendix 17. Research Methodology 18. Disclaimer Companies Mentioned Include: - Abbott Vascular - Alvimedica Medical Technologies - Arterial Remodeling Technologies - Boston Scientific Corporation - Biosensors International - Biotronik SE & Co.kG - CID S.r.l. - Clearstream Technologies Ltd. - Disa Vascular (Pty) Ltd. - Elixir Medical Corporation - Endocor Gmbh - Essen Technology (Beijing) Co., Ltd - Hexacath - Iberhospitex S.A - InspireMD, Inc. - Japan Stent Technology Co., Ltd. - Kyoto Medical - Lepu Medical Technology Co., Ltd. - Medinol - Medtronic, Inc. - Meril Life Sciences Pvt. Ltd. - Micell Technologies, Inc. - MicroPort Scientific Corporation - Minvasys - OrbusNeich - Relisys Medical Devices Limited - Terumo Medical Corporation - Translumina - Tryton Medical - Vascular Concepts For more information visit http://www.researchandmarkets.com/research/3r...talysts_to
MicroPort Scientific establishes MicroPort Orthopedics through acquisition of Wright Medical's OrthoRecon business
PR Newswire - Mon Jan 13, 9:53AM CST
MicroPort Scientific Corporation (HK: 0853), announced on January 9, 2014 the closing of the transaction to acquire the OrthoRecon business from Wright Medical Group, Inc. (NASDAQ: WMGI). The transaction establishes MicroPort Orthopedics as the sixth largest multinational hip and knee reconstruction company, with global headquarters in Arlington, Tennessee. As a result of the acquisition, MicroPort now holds U.S. manufacturing, global infrastructure, logistics and operations in the top four global orthopedic markets, as well as established hip and knee franchise brands.
MicroPort Scientific Corporation and Sorin Group Sign Joint Venture Agreement for Cardiac Rhythm Management Business in China
Business Wire - Thu Jan 09, 4:59AM CST
MicroPort Scientific Corporation (HK: 00853) and Sorin Group (MIL:SRN) (Reuters Code: SORN.MI), announced today that they have entered into a definitive agreement to form a joint venture to market and develop cardiac rhythm management (CRM) devices (implantable pacemakers, defibrillators, cardiac resynchronization devices and related devices) in China. MicroPort will hold a 51 percent stake in the joint venture entity, while Sorin will hold the remaining 49 percent interest. In accordance with the agreement, MicroPort and Sorin shall make initial capital contributions of, respectively, RMB62,220,000 (USD10.2 million) and of RMB59,780,000 (USD9.8 million) in cash in the joint-venture company.
Wright Medical Group, Inc. Reports 2013 Second Quarter Financial Results
Business Wire - Mon Aug 05, 3:00PM CDT
--Second Quarter Sales from Continuing Operations Increase 17% As Reported and 17% Constant Currency
Wright Hip Implant News: Rottenstein Law Group LLP Comments on Hip Division Sale
PRWeb - Fri Jun 21, 4:01AM CDT
The maker of the Wright Conserve and Profemur Z metal hip implants announced on June 19 that it was selling its hips and knees division. The Rottenstein Law Group LLP, which maintains Wright Conserve and Profemur Z lawsuit pages, notes that federal Conserve hip lawsuits were consolidated in court because of the device's serious alleged side effects (In re: Wright Medical Technology, Inc., Conserve Hip Implant Products Liability Litigation, MDL-2329, U.S. District Court for the Northern District of Georgia).
Neurovascular Interventions - EU Analysis and Market Forecasts to 2020
M2 - Wed May 07, 8:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nd4wcl/medipoint) has announced the addition of the "MediPoint: Neurovascular Interventions - EU Analysis and Market Forecasts" report to their offering. The global neurovascular interventions market is a vast, double-digit market that consists of innovative and emerging technologies. Rapid advances in the field of neurovascular interventions and development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. The neurovascular interventions market consists of four device segments including embolization, revascularization, mechanicalthrombectomy and access/support devices. The neurovascular interventions market in the 5EU is a vast and dynamic market that consists of innovative and emerging technologies. Neurointerventional devices can be used to treat a variety of cerebrovascular indications such as intracranial aneurysms, AVMs, and dural AVFs, atherosclerotic disease, and stroke. In this report, the neurointerventional market encompasses embolization, revascularization, mechanical thrombectomy, and access/support devices. Scope - An overview of Neurovascular, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized the EU Neurovascular market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for Neurovascular. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the Neurovascular sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors Companies Mentioned - BALT Extrusion - Covidien - Johnson & Johnson - Penumbra - Stryker Corporation - Terumo Corporation - Abbott Vascular - Boston Scientific Corporation - Cook Medical - Gore Medical - Medtronic - Aachen Resonance - Acandis - B. Braun - Blockade Medical - Contego Medical - Gardia Medical - InspireMD - ITGI Medical - Medikit - Merlin MD - MicroPort Scientific Corporation - Minvasys - Neuravi - Optimed - Phenox GmBH - Reverse Medical - Sequent Medical - Valor Medical For more information visit http://www.researchandmarkets.com/research/nd4wcl/medipoint
MediPoint Report: Neurovascular Interventions - APAC Analysis and Market Forecasts to 2020
M2 - Wed May 07, 8:38AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cn25dz/medipoint) has announced the addition of the "MediPoint: Neurovascular Interventions - APAC Analysis and Market Forecasts" report to their offering. The APAC neurovascular interventions market is a vast and dynamic market that consists of innovative and emerging technologies. Neurointerventional devices can be used to treat a variety of cerebrovascular indications such as intracranial aneurysms, AVMs, and dural AVFs, atherosclerotic disease, and stroke. In this report, the neurointerventional market encompasses embolization, revascularization, mechanical thrombectomy, and access/support devices. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Clinical Outcomes 4 Industry Overview 5 Unmet Needs 6 Market Opportunity Analysis 7 Market Drivers and Barriers 8 Competitive Assessment 9 Pipeline Assessment 10 Clinical Trial Analysis 11 Current and Future Players 12 Market Outlooks 13 Appendix Companies Mentioned - BALT Extrusion - Covidien - Johnson & Johnson - Penumbra - Stryker Corporation - Terumo Corporation - Abbott Vascular - Boston Scientific Corporation - Cook Medical - Gore Medical - Medtronic - Aachen Resonance - Acandis - B. Braun - Blockade Medical - Contego Medical - Gardia Medical - InspireMD - ITGI Medical - Medikit - Merlin MD - MicroPort Scientific Corporation - Minvasys - Neuravi - Optimed - Phenox GmBH - Reverse Medical - Sequent Medical - Valor Medical For more information visit http://www.researchandmarkets.com/research/cn25dz/medipoint
MediPoint: Neurovascular Interventions - South America Analysis and Market Forecasts to 2020
M2 - Wed May 07, 8:27AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zzfs96/medipoint) has announced the addition of the "MediPoint: Neurovascular Interventions - South America Analysis and Market Forecasts" report to their offering. The neurovascular interventions market will be driven by the rising prevalence of disease, the growing aging population, and the potential cost savings. The adoption of innovative technologies such as flow diverters and stent retrievers in Brazil will depend on the cost of, and availability of reimbursement for these devices. Flow diverters and stent retrievers are currently not reimbursed by the Brazilian public healthcare system and are associated with high costs. Scope - An overview of Neurovascular Interventions, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized South America Neurovascular Interventions market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for Neurovascular Interventions. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the Neurovascular Interventions sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors Companies Mentioned - BALT Extrusion - Covidien - Johnson & Johnson - Penumbra - Stryker Corporation - Terumo Corporation - Abbott Vascular - Boston Scientific Corporation - Cook Medical - Gore Medical - Medtronic - Aachen Resonance - Acandis - B. Braun - Blockade Medical - Contego Medical - Gardia Medical - InspireMD - ITGI Medical - Medikit - Merlin MD - MicroPort Scientific Corporation - Minvasys - Neuravi - Optimed - Phenox GmBH - Reverse Medical - Sequent Medical - Valor Medical For more information visit http://www.researchandmarkets.com/research/zzfs96/medipoint
MediPoint: US Neurovascular Interventions Analysis and Market Forecasts 2014-2020
M2 - Wed May 07, 8:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/b4sqvw/medipoint) has announced the addition of the "MediPoint: Neurovascular Interventions - US Analysis and Market Forecasts" report to their offering. The neurovascular interventions market in the US to reach $702m by 2020, increasing slowly throughout the forecast period. The neurovascular interventions market will be driven by: the rising prevalence of cerebrovascular disease; the cost savings incurred by government agencies, such as Medicare, and private health insurance companies; and the adoption of innovative technologies such as flow diverters and stent retrievers. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Clinical Outcomes 4 Industry Overview 5 Unmet Needs 6 Market Opportunity Analysis 7 Market Drivers and Barriers 8 Competitive Assessment 9 Pipeline Assessment 10 Clinical Trial Analysis 11 Current and Future Players 12 US Market Outlook 13 Appendix Companies Mentioned - BALT Extrusion - Covidien - Johnson & Johnson - Penumbra - Stryker Corporation - Terumo Corporation - Abbott Vascular - Boston Scientific Corporation - Cook Medical - Gore Medical - Medtronic - Aachen Resonance - Acandis - B. Braun - Blockade Medical - Contego Medical - Gardia Medical - InspireMD - ITGI Medical - Medikit - Merlin MD - MicroPort Scientific Corporation - Minvasys - Neuravi - Optimed - Phenox GmBH - Reverse Medical - Sequent Medical - Valor Medical For more information visit http://www.researchandmarkets.com/research/b4sqvw/medipoint
Wright Medical Group, Inc. Reports 2014 First Quarter Financial Results
Business Wire - Wed Apr 30, 3:01PM CDT
--First Quarter Sales from Continuing Operations Increase 26% As Reported and 26% Constant Currency
Global Electrophysiology Report 2014 - The Current and Future Players
M2 - Wed Apr 30, 9:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8qjsng/medipoint) has announced the addition of the "MediPoint: Electrophysiology - Current and Future Players" report to their offering. The report offers a comprehensive analysis of the global EP market, including development and sales of ablation catheters, diagnostic catheters and lab systems in the US, Germany, Italy, Spain, UK, France, China, India, Japan and Brazil. Included within is an examination of the drivers, opportunities and barriers impacting growth of the EP market worldwide, with an in-depth breakdown of the EP market seven-year global forecast. The report identifies and evaluates key trends and unmet needs shaping the global EP market through 2020, highlighting testimonials from top physicians around the world who are utilizing these devices. Future sales expectations are discussed through careful analysis of EP use adoption patterns in the ten major markets. The report identifies and analyzes the key companies shaping and driving the Electrophysiology market. The report provides insight into the competitive Electrophysiology landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading cardiologists, with in-house analysis conducted by Our team of industry experts. Scope - Investigation of current and future market competition for Electrophysiology - Competitor assessment including device approval analysis. - Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. - Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists using Electrophysiology in clinical practice. Key Topics Covered: 1 List of Tables 2 Introduction 3 Current and Future Players - Biosense Webster - Biotronik - Boston Scientific - CardioFocus - CardioInsight - Hansen Medical - Imricor - Japan Lifeline - Magnetecs Corporation - Medtronic - MicroPort Scientific Company - St. Jude Medical - Stereotaxis - Stryker Sustainability Solutions - Topera Medical 4 Pipeline Product Assessment 4.1 Pipeline Assessment by Development Stage 4.2 Segment Analysis of Pipeline Products - Ablation Catheter Pipeline Products - Diagnostic Catheter Pipeline Products 4.3 Lab Systems - Integrated X-Ray and Robotic Catheter System (Hansen Medical, Philips Healthcare) - ClearTrace System (MRI Interventions) - Robotic Catheter Guidance Lab System (North Carolina State University) - Catheter Guidance Lab System (SCR) 5 Strategic Deals Analysis 5.1 Key Acquisitions - Boston Scientific Acquires C.R. Bard's Electrophysiology Business for $275m - St. Jude Medical Acquires Endosense for $161m - Boston Scientific Acquires Rhythmia Medical for $265m 5.2 Key Partnerships - Philips and Biosense Webster Technology Integration Agreement - Biosense Webster Technology Integration Agreement with GE Healthcare Systems and Siemens Healthcare - Abbott and St. Jude Medical Broaden Alliance in US Cardiovascular Device Market 6 Appendix For more information visit http://www.researchandmarkets.com/research/8qjsng/medipoint
Global Drug-eluting Stent Market 2014-2018 with Abbott Laboratories, Boston Scientific, Medtronic & Terumo Dominating
M2 - Thu Apr 17, 5:16AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c6b9zf/global) has announced the addition of the "Global Drug-eluting Stent Market 2014-2018 with Abbott Laboratories, Boston Scientific, Medtronic & Terumo Dominating" report to their offering. One of the key drivers is the increase in the number of patients suffering from CVD. An unhealthy diet and lack of physical activity are the major factors leading to the increase in the number of people prone to CVD. Increasing demand for minimally-invasive procedures has been witnessed among members of the rapidly aging population across the world, and this is expected to boost the growth of the Global DES market. In addition, the cost efficiencies offered by less invasive methods are likely to increase the demand for the procedures in the near future. Minimally-invasive endovascular procedures are surgeries performed through minute incisions in the body. Such procedures can be used to treat plaque blockages in the arteries of the heart and other vessel walls of peripheral organs such as the kidneys and the brain. The principal advantages of these procedures over conventional surgeries are the short recovery time, the short length of the scars resulting in less physical trauma, low risk of infection, and minimized bleeding, and the shorter hospital stays associated with these surgeries. Further, the report states that the biggest challenge the market is facing is the decline in the ASP of DESs. There has been a steady decline in the prices of DESs worldwide because of the increased competition and the high rate of adoption. The reduction in the ASP has a negative impact on the overall market revenue. Key vendors dominating this space are: - Abbott Laboratories - Boston Scientific Corp - Medtronic Inc. - Terumo Corp. Other vendors mentioned in the report are: - B. Braun Melsungen AG - Biosensors International Ltd - BIOTRONIK SE & Co. KG - Cook Medical Inc. - Lepu Medical Technology Co. Ltd - MicroPort Scientific Corp. - Sorin Group USA Inc. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Types of Drugs - Geographical Segmentation - Key Leading Countries - Rate of Incidence and Prevalence - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/c6b9zf/global
ReFlow Medical and MicroPort Scientific Announce Chinese Alliance
Business Wire - Tue Apr 08, 8:02AM CDT
ReFlow Medical, Inc. (ReFlow) today announced that it has signed an exclusive distribution and sales agreement for ReFlow's suite of peripheral chronic total occlusion (CTO) products with MicroPort Endovascular (MicroPort Endo), a division of MicroPort Scientific Corporation (MicroPort), a leading medical device company in China.
Neurovascular Interventions - Global Analysis and Market Forecasts 2014
M2 - Tue Apr 08, 5:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/95ztzv/medipoint) has announced the addition of the "MediPoint: Neurovascular Interventions - Global Analysis and Market Forecasts" report to their offering. Sales of Neurointerventional Devices by Region In this report, the neurovascular interventions market encompasses embolization, revascularization, mechanical thrombectomy, and access/support devices. In 2013 in the 10MM, the neurovascular interventions market was approximately $1.37bn. We estimate the 2014 sales of neurointerventional devices for cerebrovascular applications to be $1.40bn across the 10 countries covered in this report, which are the US, France, Germany, Italy, Spain, the UK, Japan, China, India, and Brazil. Embolization, revascularization, and mechanical thrombectomy devices can be used for a wide range of cerebrovascular indications including intracranial aneurysms and arteriovenous malformations (AVMs), dural arteriovenous fistulas (DAVFs), atherosclerotic disease, and stroke. Endovascular therapy for neurovascular applications is rapidly expanding and provides effective results. The key drivers for this market during the forecast period are: - The rising prevalence of cerebrovascular disease and its associated risk factors in the major markets covered in this report. - The need for effective therapies that reduce the risk of hemorrhagic and stroke complications, and ensure long-term, reliable outcomes. - The improved outcomes with endovascular coiling for intracranial aneurysm treatment compared with surgical therapy. - The increased use of remodeling techniques such as stent-assisted and balloon-assisted coiling, and the adoption of flow diverters for the treatment of challenging/complex aneurysms (wide-neck, large, and giant aneurysms). - Improved recanalization rates with mechanical thrombectomy systems, where the need for chemical thrombolysis is eliminated, thereby reducing the risk of intracranial hemorrhage. - The cost savings for healthcare payers resulting from the reduced need for repeat procedures. - The increase in patients' disposable income and government insurance coverage in the emerging markets, such as China and India. - The approval and launch of the next-generation of innovative embolization, revascularization, and mechanical thrombectomy devices in the US and Japan. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Clinical Outcomes 4 Industry Overview 5 Unmet Needs 6 Market Opportunity Analysis 7 Market Drivers and Barriers 8 Competitive Assessment 9 Pipeline Assessment 10 Clinical Trial Analysis 11 Current and Future Players 12 Market Outlooks 13 Appendix Companies Mentioned - BALT Extrusion - Covidien - Johnson & Johnson - Penumbra - Stryker Corporation - Terumo Corporation - Abbott Vascular - Boston Scientific Corporation - Cook Medical - Gore Medical - Medtronic - Aachen Resonance - Acandis - B. Braun - Blockade Medical - Contego Medical - Gardia Medical - InspireMD - ITGI Medical - Medikit - Merlin MD - MicroPort Scientific Corporation - Minvasys - Neuravi - Optimed - Phenox GmBH - Reverse Medical - Sequent Medical - Valor Medical For more information visit http://www.researchandmarkets.com/research/95ztzv/medipoint
MediPoint: Electrophysiology - South America Analysis and Market Forecasts to 2020
M2 - Mon Apr 07, 8:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rt6lxw/medipoint) has announced the addition of the "MediPoint: Electrophysiology - South America Analysis and Market Forecasts" report to their offering. Still in its infancy, the electrophysiology (EP) device market has seen significant adoption; as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device price-points fall, and efficacy improves. This continued growth is also driven by technological advancements including the emergence of next-generation ablation technologies, improvements in catheter diagnostics, and advancements in lab systems. Further, as imaging modalities improve, patients are exposed to less radiation than ever before, which will only further drive diagnostics. Training for EP device use is severely limited in Brazil, and although it has been improving over time, it is still not ideal. While manufacturers are willing to sell devices in Brazil, support for device use has been inadequate compared with the US or countries in Europe. As a result, many physicians learn as they go, developing the skills necessary to perform complex ablation from their experiences gained using the devices during simpler procedures. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Segment Analysis 5 Market Outlooks by Geography 6 Strategic Competitive Assessment 7 Current and Future Players 8 Pipeline Product Assessment 9 Strategic Deals Analysis 10 Appendix Companies Mentioned - Biosense Webster - Biotronik - Boston Scientific - CardioFocus - CardioInsight - Hansen Medical - Imricor - Japan Lifeline - Magnetecs Corporation - Medtronic - MicroPort Scientific Company - St. Jude Medical - Stereotaxis - Stryker Sustainability Solutions - Topera Medical For more information visit http://www.researchandmarkets.com/research/rt6lxw/medipoint
MediPoint: Electrophysiology - EU Analysis and Market Forecasts 2020
M2 - Mon Mar 24, 11:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/slft2n/medipoint) has announced the addition of the "MediPoint: Electrophysiology - EU Analysis and Market Forecasts" report to their offering. Still in its infancy, the electrophysiology (EP) device market has seen significant adoption; as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device price-points fall, and efficacy improves. This continued growth is also driven by technological advancements including the emergence of next-generation ablation technologies, improvements in catheter diagnostics, and advancements in lab systems. Further, as imaging modalities improve, patients are exposed to less radiation than ever before, which will only further drive diagnostics. The EP market is dominated by several key players, with the biggest markets being in the US and European Union (EU). With improvements in reimbursement worldwide, as well as advancements of global distribution channels, devices are being sold in more hospitals and ever, and this is only expected to increase. With only a few key players currently in the market, competition remains high as industry leaders fight for valuable market share. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Segment Analysis 5 Market Outlooks by Geography 6 Strategic Competitive Assessment 7 Current and Future Players 8 Pipeline Product Assessment 9 Strategic Deals Analysis 10 Appendix Companies Mentioned - Biosense Webster - Biotronik - Boston Scientific - CardioFocus - CardioInsight - Hansen Medical - Imricor - Japan Lifeline - Magnetecs Corporation - Medtronic - MicroPort Scientific Company - St. Jude Medical - Stereotaxis - Stryker Sustainability Solutions - Topera Medical For more information visit http://www.researchandmarkets.com/research/slft2n/medipoint
MediPoint: Electrophysiology - APAC Analysis and Market Forecasts to 2020
M2 - Thu Mar 20, 10:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/z8kgmv/medipoint) has announced the addition of the "MediPoint: Electrophysiology - APAC Analysis and Market Forecasts" report to their offering. Still in its infancy, the electrophysiology (EP) device market has seen significant adoption; as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device price-points fall, and efficacy improves. This continued growth is also driven by technological advancements including the emergence of next-generation ablation technologies, improvements in catheter diagnostics, and advancements in lab systems. Further, as imaging modalities improve, patients are exposed to less radiation than ever before, which will only further drive diagnostics. Growth in emerging markets is expected to drive sales as developing countries look to implement new EP programs, and hospitals adopt ablation techniques. Lastly, published studies, clinical evidence, and patient awareness will all contribute positively to EP market growth and will provide further evidence of the effectiveness of cardiac catheter ablation. Scope - An overview of electrophysiology, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized APAC electrophysiology market revenue from 2005 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for electrophysiology - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the electrophysiology sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Segment Analysis 5 Market Outlooks by Geography 6 Strategic Competitive Assessment 7 Current and Future Players 8 Pipeline Product Assessment 9 Strategic Deals Analysis 10 Appendix Companies Mentioned - Biosense Webster - Biotronik - Boston Scientific - CardioFocus - CardioInsight - Hansen Medical - Imricor - Japan Lifeline - Magnetecs Corporation - Medtronic - MicroPort Scientific Company - St. Jude Medical - Stereotaxis - Stryker Sustainability Solutions - Topera Medical For more information visit http://www.researchandmarkets.com/research/z8kgmv/medipoint
Concise Analysis of the International Intracranial Stents Market
M2 - Thu Mar 13, 6:28AM CDT
Research and Markets (http://www.researchandmarkets.com/research/r4fntp/intracranial) has announced the addition of the "Concise Analysis of the International Intracranial Stents Market" report to their offering. This report analyzes the worldwide markets for Intracranial Stents in US$ Thousands. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a five-year historic analysis is provided for these markets. The report profiles 16 companies including many key and niche players such as: - Admedes Schuessler GmbH - BALT Extrusion - Cardiatis SA - Codman & Shurtleff, Inc. - Covidien PLC - ITGI Medical Ltd. - Medtronic, Inc. - MicroPort Scientific Corporation - OBEX Medical - Penumbra, Inc. - Stryker Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Market Drivers, Issues & Challenges 3. Product Overview 4. Neurovascular Diseases - An Overview 5. Product Introductions & Approvals 6. Recent Industry Activity 7. Focus On Select Players 8. Global Market Perspective III. Market 1. The United States 2. Europe 3. Rest Of World IV. Competitive Landscape Total Companies Profiled: 16 (including Divisions/Subsidiaries - 18) - The United States (7) - Europe (6) - France (1) - Germany (3) - Rest of Europe (2) - Asia-Pacific (Excluding Japan) (4) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/r4...tracranial About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Electrophysiology Market Value to Almost Double by 2020, as Arrhythmia Incidence Continues to Grow
M2 - Tue Mar 04, 3:40AM CST
Research and Markets (http://www.researchandmarkets.com/research/szcgxs/medipoint) has announced the addition of the "MediPoint: Electrophysiology - Global Analysis and Market Forecasts" report to their offering. Global Electrophysiology Market Value to Almost Double by 2020, as Arrhythmia Incidence Continues to Grow The global electrophysiology (EP) market, consisting of ablation catheters, diagnostic catheters and lab systems, is set to experience rapid growth in value over the coming years, climbing from approximately $1.56 billion in 2013 to $2.93 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 9.5%, says research and consulting firm The authors. The company's new report* forecasts that standard diagnostic catheters will achieve the largest revenue in the EP market by 2020, with a share of $2,493 million, followed by advanced diagnostic catheters and standard ablation catheters, with shares of $1,223 million and $575 million, respectively. According to the authors, this rapid EP industry growth is due to an increasing incidence of arrhythmia, along with rising market penetration of diagnostic and ablation catheters in the Asia-Pacific and South American regions. Rob Littlefield, MSc, Senior Analyst covering Medical Devices, says: Medical centers that support ablation are increasingly desirable as the global occurrence of cardiac dyssynchrony continues to rise. While atrial fibrillation and ventricular fibrillation are the most common indications for treatment, heart failure, diabetes and obesity can all contribute to ongoing rhythm management concerns. The authors states that the current EP market is extremely competitive and dominated by several key players, which must continue to innovate in the face of mounting price pressure and strict regulation, as new entrants battle to gain market share. Up-and-coming technologies in development, including alternative forms of energy such as cryo-, ultrasound- and laser-ablation, as well as advanced mapping and navigation technologies, promise to increase product sales and new account openings. Meanwhile, industry standards continue to develop in relation to ablation strategies for treatment, therefore improving patient outcomes, Littlefield concludes. This report provides a comprehensive analysis of the global electrophysiology market, including development and sales of ablation catheters, diagnostic catheters and lab systems in the US, Germany, Italy, Spain, the UK, France, China, India, Japan and Brazil. Key Topics Covered: List of Tables List of Figures Introduction Industry Overview Segment Analysis Market Outlooks by Market Segment Market Outlooks by Geography Strategic Competitive Assessment Current and Future Players Pipeline Product Assessment Strategic Deals Analysis Appendix List of Tables List of Figures Companies Mentioned Biosense Webster Biotronik Boston Scientific CardioFocus CardioInsight Hansen Medical Imricor Japan Lifeline Magnetecs Corporation Medtronic MicroPort Scientific Company St. Jude Medical Stereotaxis Stryker Sustainability Solutions Topera Medical For more information visit http://www.researchandmarkets.com/research/szcgxs/medipoint About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Drug-eluting Stent Market 2014-2018: The Biggest Challenge the Market is Facing is the Decline in the ASP of DESs
M2 - Mon Feb 17, 8:46AM CST
Research and Markets (http://www.researchandmarkets.com/research/gprmns/global) has announced the addition of the "Global Drug-eluting Stent Market 2014-2018" report to their offering. The analysts forecast the Global Drug-eluting Stent (DES) market to grow at a CAGR of 5.79 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing prevalence of CVD. The Global Drug-eluting Stent (DES) market has also been witnessing the increasing demand for minimally invasive procedures. However, the decline in the average selling price of drug eluting stents could pose a challenge to the growth of this market. Key vendors dominating this space are Abbott Laboratories, Boston Scientific Corp., Medtronic Inc., and Terumo Corp. Other vendors mentioned in the report are B. Braun Melsungen AG, Biosensors International Ltd., BIOTRONIK SE & Co. KG, Cook Medical Inc., Lepu Medical Technology Co. Ltd., MicroPort Scientific Corp., and Sorin Group USA Inc. Commenting on the report, an analyst from the team said: Increasing demand for minimally-invasive procedures has been witnessed among members of the rapidly aging population across the world, and this is expected to boost the growth of the Global DES market. In addition, the cost efficiencies offered by less invasive methods are likely to increase the demand for the procedures in the near future. Minimally-invasive endovascular procedures are surgeries performed through minute incisions in the body. Such procedures can be used to treat plaque blockages in the arteries of the heart and other vessel walls of peripheral organs such as the kidneys and the brain. The principal advantages of these procedures over conventional surgeries are the short recovery time, the short length of the scars resulting in less physical trauma, low risk of infection, and minimized bleeding, and the shorter hospital stays associated with these surgeries. According to the report, one of the key drivers is the increase in the number of patients suffering from CVD. An unhealthy diet and lack of physical activity are the major factors leading to the increase in the number of people prone to CVD. For more information visit http://www.researchandmarkets.com/research/gprmns/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
3 Catalysts To Catapult Global Coronary Stent Market To $13 Billion by 2019
M2 - Mon Jan 27, 9:45AM CST
Research and Markets (http://www.researchandmarkets.com/research/3rr9nj/3_catalysts_to) has announced the addition of the "3 Catalysts To Catapult Global Coronary Stent Market To $13 Billion" report to their offering. The global coronary stent market is expected to be over $13 billion by 2019, despite the current downward trend in the US, the largest market, and declining selling prices globally. Increasing PCI (percutaneous coronary intervention) procedures triggered by the rising prevalence of CAD (coronary artery disease), novel technologies in pipeline addressing the unmet needs, uptake of Bioabsorbable stents and impressive growth in APAC region have the potential to upswing the fortunes of the market that has remained stagnant for a few years. The market study takes into account various global clinical studies and pipeline products and it suggests that the coronary stent pipeline is clustered with new generation Drug Eluting Stent (DES), bioactive stents, bioabsorbable technology and stents for the niche segments such as complex and bifurcated vessels. Altering the trend, small to medium size companies from the developing economies are ambitiously conducting clinical studies to win the approvals and expand the use of devices for new indications. The stent market globally and in the developed nations is largely controlled by three players - Abbott Laboratories, Boston Scientific, and Medtronic. While in developing economies, small and medium players from Asia and Europe have a considerable share in terms of volume. This comprehensive, 465 page global strategic business report is authored by a team of sector analysts who used rigorous primary and secondary research and robust analytical models to provide strategic insight and to forecast for all major stent types BMS, DES, Bioabsorbable stents in leading 23 geographies. Data at global, continents, economic zones, and country level: - Market size of coronary stents in terms - value and volume (2005-2019) for BMS, DES and Bioabsorbables (Bioresorbable - BVS) - Market growth rates (2005-2019) - Average prices of various stents in all the covered geographies (2005-2019) - Number of PCI procedures - Analytical comparison between different continents and economic regions - Market dynamics - market trends, drivers, restrains, issues, competitive landscape - Detailed pipeline and clinical studies - Product approval status - major geographies - Industry consolidation, partnerships, product launches, approvals and recalls - Detailed company profiles of around 70 companies from different levels of value chain Key Topics Covered: 1. Charts & Tables 2. Executive Summary 3. Market at a Glance 4. Introduction to Stents 5. Coronary Stents 6. Types of Stents 7. Approvals 8. Competitive Landscape 9. Clinical Studies 10.Coronary Stents - Market Drivers and Restrains 11.Overview: Market trends 12.Approvals Driving the Growth 13. Market Data 14.Company Profiles 15.Recent Events 16.Appendix 17. Research Methodology 18. Disclaimer Companies Mentioned Include: - Abbott Vascular - Alvimedica Medical Technologies - Arterial Remodeling Technologies - Boston Scientific Corporation - Biosensors International - Biotronik SE & Co.kG - CID S.r.l. - Clearstream Technologies Ltd. - Disa Vascular (Pty) Ltd. - Elixir Medical Corporation - Endocor Gmbh - Essen Technology (Beijing) Co., Ltd - Hexacath - Iberhospitex S.A - InspireMD, Inc. - Japan Stent Technology Co., Ltd. - Kyoto Medical - Lepu Medical Technology Co., Ltd. - Medinol - Medtronic, Inc. - Meril Life Sciences Pvt. Ltd. - Micell Technologies, Inc. - MicroPort Scientific Corporation - Minvasys - OrbusNeich - Relisys Medical Devices Limited - Terumo Medical Corporation - Translumina - Tryton Medical - Vascular Concepts For more information visit http://www.researchandmarkets.com/research/3r...talysts_to
MicroPort Scientific establishes MicroPort Orthopedics through acquisition of Wright Medical's OrthoRecon business
PR Newswire - Mon Jan 13, 9:53AM CST
MicroPort Scientific Corporation (HK: 0853), announced on January 9, 2014 the closing of the transaction to acquire the OrthoRecon business from Wright Medical Group, Inc. (NASDAQ: WMGI). The transaction establishes MicroPort Orthopedics as the sixth largest multinational hip and knee reconstruction company, with global headquarters in Arlington, Tennessee. As a result of the acquisition, MicroPort now holds U.S. manufacturing, global infrastructure, logistics and operations in the top four global orthopedic markets, as well as established hip and knee franchise brands.
MicroPort Scientific Corporation and Sorin Group Sign Joint Venture Agreement for Cardiac Rhythm Management Business in China
Business Wire - Thu Jan 09, 4:59AM CST
MicroPort Scientific Corporation (HK: 00853) and Sorin Group (MIL:SRN) (Reuters Code: SORN.MI), announced today that they have entered into a definitive agreement to form a joint venture to market and develop cardiac rhythm management (CRM) devices (implantable pacemakers, defibrillators, cardiac resynchronization devices and related devices) in China. MicroPort will hold a 51 percent stake in the joint venture entity, while Sorin will hold the remaining 49 percent interest. In accordance with the agreement, MicroPort and Sorin shall make initial capital contributions of, respectively, RMB62,220,000 (USD10.2 million) and of RMB59,780,000 (USD9.8 million) in cash in the joint-venture company.
Wright Medical Group, Inc. Reports 2013 Second Quarter Financial Results
Business Wire - Mon Aug 05, 3:00PM CDT
--Second Quarter Sales from Continuing Operations Increase 17% As Reported and 17% Constant Currency
Wright Hip Implant News: Rottenstein Law Group LLP Comments on Hip Division Sale
PRWeb - Fri Jun 21, 4:01AM CDT
The maker of the Wright Conserve and Profemur Z metal hip implants announced on June 19 that it was selling its hips and knees division. The Rottenstein Law Group LLP, which maintains Wright Conserve and Profemur Z lawsuit pages, notes that federal Conserve hip lawsuits were consolidated in court because of the device's serious alleged side effects (In re: Wright Medical Technology, Inc., Conserve Hip Implant Products Liability Litigation, MDL-2329, U.S. District Court for the Northern District of Georgia).
